Benjamin Sanders

Ben received his B.S. in Behavioral Neuroscience from Northeastern University, where he completed three research co-op’s at Harvard Medical School, Merck, and Massachusetts General Hospital. As a PhD student in the Lim Lab, he is focusing on the cell-type specific role of Nemo-Like Kinase (NLK) and lysosome regulation in the context of protein quality control in neurodegenerative diseases such as spinocerebellar ataxia type 1 (SCA1), Alzheimer’s disease, frontotemporal demential (FTD/FTLD), and amyotrophic lateral sclerosis (ALS).